OTX-14-002: Device Exposure Registry

NCT02309736 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-02-05

No results posted yet for this study

Summary

The objective of the study is to collect post-approval data relative to the incidence of endophthalmitis for cataract surgery patients treated with the FDA-approved ReSure Sealant when used by a broad group of physicians under commercial use conditions

Conditions

  • Endophthalmitis

Interventions

DEVICE

ReSure Sealant

Sponsors & Collaborators

  • Ocular Therapeutix, Inc.

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Primary Completion
2020-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02309736 on ClinicalTrials.gov